<?xml version="1.1" encoding="UTF-8" standalone="yes"?><xml><head><creation_date>D:20060309122657+01'00'</creation_date><modification_date>D:20060321203424+01'00'</modification_date><initial_authorization>False</initial_authorization><pdf_file>EU-1-00-131_h_dec_3.pdf</pdf_file></head><body><section><header>commission of the european communities brussels, 06.02.2002 c(2002) 494 
  not for publication</header></section><section><header>commission decision of 06.02.2002 
 amending decision c(2000) 1407 on the marketing authorisation for the medicinal 
 product for human use  
  
 &quot; pegintron - peginterferon alfa-2b &quot; 
 only the french and the dutch texts are authentic 
  
 (text with eea relevance)</header></section><section><header>commission decision of 06.02.2002 
 amending decision c(2000) 1407 on the marketing authorisation for the medicinal 
 product for human use  
  
 &quot; pegintron - peginterferon alfa-2b &quot; 
 (text with eea relevance)</header><p>the commission of the european communities, having regard to the treaty establishing the european community, 
 having regard to council regulation (eec) no 2309/93 of 22 july 1993 laying down 
 community procedures for the authorization and supervision of medicinal products for human 
 and veterinary use and establishing a european agency for the evaluation of medicinal 
 products,
 1 as amended by commission regulation (ec) no 649/98,2 and in particular article 10(2) thereof, 
 having regard to commission regulation (ec) no 542/95 of 10 march 1995 concerning the 
 examination of variations to the terms of a marketing authorization falling within the scope of 
 council regulation (eec) no 2309/93,
 3 as amended by commission regulation (ec) no 1069/98,
 4 and in particular annex ii thereto, having regard to the opinion of the european agency for the evaluation of medicinal 
 products, 
 whereas: 
 (1)</p><p>the medicinal product “pegintron - peginterferon alfa-2b” entered in the community 
 register of medicinal products under nos eu/1/00/131/001-030 authorised by 
 commission decision c(2000) 1407 of 25 may 2000, as amended, complies with the 
 requirements set out in regulation (eec) no 2309/93. 
 (2)</p><p>sp europe submitted an application on 30 january 2001 pursuant to annex ii to 
 regulation (ec) no 542/95 and article 4(1) of regulation (eec) no 2309/93. 
 (3)</p><p>the european agency for the evaluation of medicinal products delivered a favourable 
 opinion formulated on 20 september 2001 by the committee for proprietary 
 medicinal products. 
 (4)</p><p>decision c(2000) 1407 should therefore be amended accordingly.</p><p>
 1 oj l 214, 24.8.1993, p. 1. 2 oj l 88, 24.3.1998, p. 7. 3 oj l 55, 11.3.1995, p. 15. 4 oj l 153, 27.5.1998, p. 11.</p><p>(5) the measures provided for in this decision are in accordance with the opinion of the 
 standing committee on medicinal products for human use, 
 has adopted this decision:</p><p>
 article 1 decision c(2000) 1407 is hereby amended as follows: a) 
 the following numbers are added to article 1: 
 eu/1/00/131/031 – pegintron</p><p>- 50 micrograms - powder and solvent for solution for injection 
 in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge (glass) in a 
 pre-filled pen - 50 µg (50 µg/0.5 ml) - 1 pen+1 injection needle+2 cleansing swabs</p><p>
 eu/1/00/131/032 - pegintron</p><p>- 50 micrograms - powder and solvent for solution for injection 
 in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge (glass) in a 
 pre-filled pen - 50 µg (50 µg/0.5 ml) - 4 pens+4 injection needles+8 cleansing swabs</p><p> eu/1/00/131/033 - pegintron</p><p>- 50 micrograms - powder and solvent for solution for injection 
 in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge (glass) in a 
 pre-filled pen - 50 µg (50 µg/0.5 ml) - 6 pens+6 injection needles+12 cleansing swabs</p><p>eu/1/00/131/034 - pegintron</p><p>- 50 micrograms - powder and solvent for solution for injection 
 in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge (glass) in a 
 pre-filled pen - 50 µg (50 µg/0.5 ml) - 12 pens+12 injection needles+24 cleansing swabs</p><p>eu/1/00/131/035 - pegintron</p><p>- 80 micrograms - powder and solvent for solution for injection 
 in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge (glass) in a 
 pre-filled pen - 80 µg (80 µg/0.5 ml) - 1 pen+1 injection needle+2 cleansing swabs</p><p>eu/1/00/131/036 - pegintron</p><p>- 80 micrograms - powder and solvent for solution for injection 
 in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge (glass) in a 
 pre-filled pen - 80 µg (80 µg/0.5 ml) - 4 pens+4 injection needles+8 cleansing swabs</p><p> eu/1/00/131/037 - pegintron</p><p>- 80 micrograms - powder and solvent for solution for injection 
 in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge (glass) in a 
 pre-filled pen - 80 µg (80 µg/0.5 ml) - 6 pens+6 injection needles+12 cleansing swabs</p><p>eu/1/00/131/038 - pegintron</p><p>- 80 micrograms - powder and solvent for solution for injection 
 in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge (glass) in a 
 pre-filled pen - 80 µg (80 µg/0.5 ml) - 12 pens+12 injection needles+24 cleansing swabs</p><p>eu/1/00/131/039 - pegintron</p><p>- 100 micrograms - powder and solvent for solution for 
 injection in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge 
 (glass) in a pre-filled pen - 100 µg (100 µg/0.5 ml) - 1 pen+1 injection needle+2 cleansing 
 swabs</p><p>eu/1/00/131/040 - pegintron</p><p>- 100 micrograms - powder and solvent for solution for 
 injection in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge 
 (glass) in a pre-filled pen - 100 µg (100 µg/0.5 ml) - 4 pens+4 injection needles+8 cleansing 
 swabs</p><p>eu/1/00/131/041 - pegintron</p><p>-100 micrograms - powder and solvent for solution for injection in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge 
 (glass) in a pre-filled pen - 100 µg (100 µg/0.5 ml) - 6 pens+6 injection needles+12 cleansing 
 swabs</p><p>eu/1/00/131/042 - pegintron</p><p>- 100 micrograms - powder and solvent for solution for 
 injection in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge 
 (glass) in a pre-filled pen - 100 µg (100 µg/0.5 ml) - 12 pens+12 injection needles+24 
 cleansing swabs</p><p>eu/1/00/131/043 - pegintron</p><p>- 120 micrograms - powder and solvent for solution for 
 injection in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge 
 (glass) in a pre-filled pen - 120 µg (120 µg/0.5 ml)-1 pen+1 injection needle+2 cleansing 
 swabs</p><p>eu/1/00/131/044 - pegintron</p><p>- 120 micrograms - powder and solvent for solution for 
 injection in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge 
 (glass) in a pre-filled pen - 120 µg (120 µg/0.5 ml) - 4 pens+4 injection needles+8 cleansing 
 swabs</p><p> eu/1/00/131/045 - pegintron</p><p>- 120 micrograms - powder and solvent for solution for 
 injection in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge 
 (glass) in a pre-filled pen - 120 µg (120 µg/0.5 ml) - 6 pens+6 injection needles+12 cleansing 
 swabs</p><p>eu/1/00/131/046 - pegintron</p><p>- 120 micrograms - powder and solvent for solution for 
 injection in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge 
 (glass) in a pre-filled pen - 120 µg (120 µg/0.5 ml) - 12 pens+12 injection needles+24 
 cleansing swabs</p><p>eu/1/00/131/047 - pegintron</p><p>- 150 micrograms - powder and solvent for solution for 
 injection in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge 
 (glass) in a pre-filled pen - 150 µg (150 µg/0.5 ml)-1 pen+1 injection needle+2 cleansing 
 swabs</p><p>eu/1/00/131/048 - pegintron</p><p>- 150 micrograms - powder and solvent for solution for 
 injection in pre-filled pen - subcutaneous use-powder and solvent: two chamber cartridge 
 (glass) in a pre-filled pen -150 µg (150 µg/0.5 ml) - 4 pens+4 injection needles+8 cleansing 
 swabs</p><p> eu/1/00/131/049 - pegintron</p><p>- 150 micrograms - powder and solvent for solution for 
 injection in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge 
 (glass) in a pre-filled pen - 150 µg (150 µg/0.5 ml) - 6 pens+6 injection needles+12 cleansing 
 swabs 
 eu/1/00/131/050 - pegintron</p><p>- 150 micrograms - powder and solvent for solution for 
 injection in pre-filled pen - subcutaneous use - powder and solvent: two chamber cartridge 
 (glass) in a pre-filled pen - 150 µg (150 µg/0.5 ml) - 12 pens+12 injection needles+24 
 cleansing swabs</p><p>b) 
 the text set out in annex i to this decision is added to annex i. 
 c) 
 the text set out in annex ii to this decision is added to annex ii.</p><p>d) the text set out in annex iii(a) and (b) to this decision is added to annex iii(a) and 
 (b) respectively. 
 article 2 this decision is addressed to sp europe, rue de stalle, 73, 1180 bruxelles, belgique – sp europe, stallestraat, 73 – 1180 brussel, belgië. 
 done at brussels, 06.02.2002</p><p>for the commission</p><p>
 erkki liikanen</p><p>
 member of the commission</p></section></body></xml>